Viracta Therapeutics shares owned by Aisling Capital Management
Quarter-by-quarter ownership of Viracta Therapeutics (VIRX) shares owned by Aisling Capital Management
from 13F filings
Historical chart of Aisling Capital Management investment in Viracta Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Viracta Therapeutics held by Aisling Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Viracta Therapeutics by Aisling Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $165k | 289k | 0.57 |
| 2023-09-30 | $300k | 289k | 1.04 |
| 2023-06-30 | $407k | 289k | 1.41 |
| 2023-03-31 | $459k | 289k | 1.59 |
| 2022-12-31 | $421k | 289k | 1.46 |
| 2022-09-30 | $1.2M | 289k | 4.27 |
| 2022-06-30 | $1.1M | 289k | 3.88 |
| 2022-03-31 | $1.4M | 289k | 4.76 |
| 2021-12-31 | $1.1M | 289k | 3.65 |
| 2021-09-30 | $2.3M | 289k | 8.02 |
| 2021-06-30 | $3.3M | 289k | 11.34 |
More positions owned by Aisling Capital Management
View all positions for Aisling Capital Management